Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-22-023306
Filing Date
2022-09-30
Accepted
2022-09-30 16:17:15
Documents
5
Period of Report
2022-11-10

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A nby20220921_def14a.htm DEF 14A 377024
2 logo01.jpg GRAPHIC 9343
3 prxy01.jpg GRAPHIC 157864
4 prxy02.jpg GRAPHIC 153636
5 sig01.jpg GRAPHIC 8243
  Complete submission text file 0001437749-22-023306.txt   831353
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33678 | Film No.: 221284259
SIC: 2834 Pharmaceutical Preparations